Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Liabilities and Shareholders Equity (2018 - 2025)

AVITA Medical filings provide 8 years of Liabilities and Shareholders Equity readings, the most recent being $56.4 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 29.25% to $56.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $247.8 million, a 28.37% decrease, with the full-year FY2025 number at $56.4 million, down 29.25% from a year prior.
  • Liabilities and Shareholders Equity hit $56.4 million in Q4 2025 for AVITA Medical, down from $63.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $128.1 million in Q1 2021 to a low of $56.4 million in Q4 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $95.0 million (2023), compared with a mean of $93.2 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 67.4% in 2021 and later crashed 33.81% in 2025.
  • AVITA Medical's Liabilities and Shareholders Equity stood at $116.0 million in 2021, then fell by 15.3% to $98.3 million in 2022, then increased by 13.61% to $111.6 million in 2023, then decreased by 28.6% to $79.7 million in 2024, then decreased by 29.25% to $56.4 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $56.4 million (Q4 2025), $63.7 million (Q3 2025), and $58.1 million (Q2 2025) per Business Quant data.